Ted W. Love - 01 Aug 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc.

Role: President and CEO, Director
Signature: /s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 01 Aug 2022
Net transactions value: -$324,583
Form type: 4
Filing time: 03 Aug 2022, 18:01:22 UTC
Previous filing: 24 Jun 2022
Next filing: 06 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GBT	Common Stock	Options Exercise		+20,205	+2.5%		815,192	01 Aug 2022	Direct	F1
transaction	GBT	Common Stock	Tax liability	$324,583	-10,018	-1.2%	$32.40	805,174	01 Aug 2022	Direct	F2
holding	GBT	Common Stock						102,000	01 Aug 2022	By Trust 1
holding	GBT	Common Stock						102,000	01 Aug 2022	By Trust 2
holding	GBT	Common Stock						102,000	01 Aug 2022	By Trust 3
holding	GBT	Common Stock						2,500	01 Aug 2022	By Daughter
holding	GBT	Common Stock						2,500	01 Aug 2022	By Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GBT	Restricted Stock Units	Options Exercise	$0	-11,250	-50%	$0.000000	11,250	01 Aug 2022	Common Stock	11,250		Direct	F1, F3
transaction	GBT	Restricted Stock Units	Options Exercise	$0	-8,955	-25%	$0.000000	26,865	01 Aug 2022	Common Stock	8,955		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 20,205 shares of Common Stock underlying the Reporting Person's RSUs.
F3	The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F4	The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from February 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.